Detalles de la búsqueda
1.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 25(5): 572-587, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561010
2.
Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinoma.
Future Oncol
; 18(17): 2087-2099, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35240857
3.
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048.
Int J Clin Oncol
; 27(12): 1805-1817, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264378
4.
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.
Mod Pathol
; 34(3): 532-541, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239737
5.
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Lancet
; 393(10167): 156-167, 2019 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30509740
6.
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104).
Breast Cancer Res Treat
; 165(2): 375-382, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28623430
7.
p16 status and choice of chemotherapy in the KEYNOTE-040 study - Authors' reply.
Lancet
; 394(10206): 1323, 2019 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609223
8.
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.
Lancet Oncol
; 15(10): 1137-46, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130998
9.
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
J Clin Oncol
; 41(4): 790-802, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219809
10.
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.
Dermatol Ther (Heidelb)
; 13(12): 3165-3180, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943491
11.
Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation.
Breast J
; 18(5): 415-9, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22776042
12.
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.
J Clin Oncol
; 40(21): 2321-2332, 2022 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35333599
13.
Circulating tumor cells in breast cancer: a tool whose time has come of age.
BMC Med
; 9: 43, 2011 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21510857
14.
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
J Natl Cancer Inst
; 113(2): 171-181, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32407532
15.
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
Dermatol Ther (Heidelb)
; 11(5): 1777-1790, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558040
16.
History of smoking is associated with younger age at diagnosis of breast cancer.
Breast J
; 16(4): 344-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20443785
17.
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629).
J Clin Oncol
; 38(25): 2916-2925, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673170
18.
Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.
J Surg Oncol
; 100(1): 25-31, 2009 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19373863
19.
Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.
Cancer Res
; 67(4): 1494-501, 2007 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17308087
20.
Low-dose estrogen therapy to reverse acquired antihormonal resistance in the treatment of breast cancer.
Clin Breast Cancer
; 8(2): 124-33, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621608